These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 12764576)

  • 1. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
    Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
    Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
    Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening assay for new ligands at human melatonin receptors.
    Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
    Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17Beta-estradiol modulates hMT1 melatonin receptor function.
    Masana MI; Soares JM; Dubocovich ML
    Neuroendocrinology; 2005; 81(2):87-95. PubMed ID: 15809517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
    Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
    J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
    Hu Y; Chan KH; He X; Ho MK; Wong YH
    PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New radioligands for describing the molecular pharmacology of MT1 and MT2 melatonin receptors.
    Legros C; Matthey U; Grelak T; Pedragona-Moreau S; Hassler W; Yous S; Thomas E; Suzenet F; Folleas B; Lefoulon F; Berthelot P; Caignard DH; Guillaumet G; Delagrange P; Brayer JL; Nosjean O; Boutin JA
    Int J Mol Sci; 2013 Apr; 14(5):8948-62. PubMed ID: 23698757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.
    Landagaray E; Ettaoussi M; Duroux R; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
    Eur J Med Chem; 2016 Feb; 109():360-70. PubMed ID: 26820449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
    Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
    Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
    Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
    J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.
    Landagaray E; Ettaoussi M; Leclerc V; Traoré B; Perez V; Nosjean O; Boutin JA; Caignard DH; Delagrange P; Berthelot P; Yous S
    Bioorg Med Chem; 2014 Feb; 22(3):986-96. PubMed ID: 24417958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors.
    Mailliet F; Audinot V; Malpaux B; Bonnaud A; Delagrange P; Migaud M; Barrett P; Viaud-Massuard MC; Lesieur D; Lefoulon F; Renard P; Boutin JA
    Biochem Pharmacol; 2004 Feb; 67(4):667-77. PubMed ID: 14757166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking studies for melatonin receptors.
    Alkozi HA; Sánchez Montero JM; Doadrio AL; Pintor J
    Expert Opin Drug Discov; 2018 Mar; 13(3):241-248. PubMed ID: 29271261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of the constitutive activity of cloned human melatonin receptors hMT(1) and hMT(2) and discovery of inverse agonists.
    Devavry S; Legros C; Brasseur C; Delagrange P; Spadoni G; Cohen W; Malpaux B; Boutin JA; Nosjean O
    J Pineal Res; 2012 Aug; 53(1):29-37. PubMed ID: 22017484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
    Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
    Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the Melatonin Receptor. 8. Selective MT2 Agonists Derived from 5,6-Dihydroindolo[2,1-a]isoquinolines and Related Systems.
    Tsotinis A; Afroudakis PA; Papanastasiou IP; Sakellaropoulou A; Boniakou M; Komiotis D; Garratt PJ; Delagrange P; Bocianowska-Zbrog A; Sugden D
    ChemMedChem; 2022 Jun; 17(12):e202200129. PubMed ID: 35478275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
    Stein RM; Kang HJ; McCorvy JD; Glatfelter GC; Jones AJ; Che T; Slocum S; Huang XP; Savych O; Moroz YS; Stauch B; Johansson LC; Cherezov V; Kenakin T; Irwin JJ; Shoichet BK; Roth BL; Dubocovich ML
    Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.
    Mésangeau C; Fraise M; Delagrange P; Caignard DH; Boutin JA; Berthelot P; Yous S
    Eur J Med Chem; 2011 May; 46(5):1835-40. PubMed ID: 21392858
    [TBL] [